Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FTC Enjoins Warner Chilcott From Providing “Anything Of Value” To ANDA Filers

This article was originally published in The Pink Sheet Daily

Executive Summary

Commission settles charges against the brand drug maker related to generic Ovcon 35.

You may also be interested in...



FTC “Barrs” Firm From Anticompetitive Agreements

Federal Trade Commission gets rare victory in settlement with Barr over charges that cash payment delayed entry of generic Ovcon.

FTC “Barrs” Firm From Anticompetitive Agreements

Federal Trade Commission gets rare victory in settlement with Barr over charges that cash payment delayed entry of generic Ovcon.

Plavix Settlement Outcome May Make Industry Overly Cautious, Legal Experts Say

Collapse of Bristol/Sanofi generic settlement with Apotex will likely impact future brand-generic negotiations, attorneys predict.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS063252

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel